Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Maraganore

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Neurology|September 15, 2005
LRRK2 mutations in Parkinson diseaseM Farrer, J Stone, I F Mata, et al.
Neurology|May 1, 1997
A population perspective on diagnostic criteria for Parkinson's diseaseM C de Rijk, W A Rocca, D W Anderson, et al.
Archives of Neurology|December 1, 1994
Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergolineJ E Ahlskog, M D Muenter, D M Maraganore, et al.
Mayo Clinic Proceedings|July 16, 1999
Detection of preclinical Parkinson disease in at-risk family members with use of [123I]beta-CIT and SPECT: an exploratory studyD M Maraganore, M K O'Connor, J H Bower, et al.
Neurology|October 1, 1993
Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County projectR J Uitti, J E Ahlskog, D M Maraganore, et al.
Neurology|September 1, 2007
Increased risk of parkinsonism in women who underwent oophorectomy before menopauseW A Rocca, J H Bower, D M Maraganore, et al.
Neurology|September 1, 2007
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopauseW A Rocca, J H Bower, D M Maraganore, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 1998
Case ascertainment uncertainties in prevalence surveys of Parkinson's diseaseD W Anderson, W A Rocca, M C de Rijk, et al.
Neurology|October 1, 1993
Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopaA Lieberman, S Imke, M Muenter, et al.
Neurology|November 26, 2009
Medical records documentation of constipation preceding Parkinson disease: A case-control studyR Savica, J M Carlin, B R Grossardt, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Neurology|September 15, 2005
LRRK2 mutations in Parkinson diseaseM Farrer, J Stone, I F Mata, et al.
Neurology|May 1, 1997
A population perspective on diagnostic criteria for Parkinson's diseaseM C de Rijk, W A Rocca, D W Anderson, et al.
Archives of Neurology|December 1, 1994
Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergolineJ E Ahlskog, M D Muenter, D M Maraganore, et al.
Mayo Clinic Proceedings|July 16, 1999
Detection of preclinical Parkinson disease in at-risk family members with use of [123I]beta-CIT and SPECT: an exploratory studyD M Maraganore, M K O'Connor, J H Bower, et al.
Neurology|October 1, 1993
Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County projectR J Uitti, J E Ahlskog, D M Maraganore, et al.
Neurology|September 1, 2007
Increased risk of parkinsonism in women who underwent oophorectomy before menopauseW A Rocca, J H Bower, D M Maraganore, et al.
Neurology|September 1, 2007
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopauseW A Rocca, J H Bower, D M Maraganore, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 1998
Case ascertainment uncertainties in prevalence surveys of Parkinson's diseaseD W Anderson, W A Rocca, M C de Rijk, et al.
Neurology|October 1, 1993
Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopaA Lieberman, S Imke, M Muenter, et al.
Neurology|November 26, 2009
Medical records documentation of constipation preceding Parkinson disease: A case-control studyR Savica, J M Carlin, B R Grossardt, et al.
Pageof 7